PDF(Pubmed)
Abstract：
UNASSIGNED: This study examined the association between patient experience (PX, events experienced by patients during primary care that are an indicator of patient-centered quality) of primary care and varicella-zoster virus (VZV) vaccine uptake in older adults.
UNASSIGNED: A case-control study of VZV vaccination was conducted at a community hospital in Ibaraki, Japan. Patients aged 65 years or older who had continuously been patients of the hospital between April 2018 and April 2021 were included in the study. The vaccinated group consisted of 166 VZV-vaccinated patients. The controls consisted of 29 age- and sex-matched patients who did not receive VZV vaccination. A self-administered questionnaire was distributed between August and September 2021. It included the Japanese version of the Primary Care Assessment Tool Short Form (JPCAT-SF) to evaluate PX and included questions about recommendations for VZV vaccination by a physician and the vaccination history of relatives. Multivariable and intermediate factor analyses were used to assess whether there was an association between VZV vaccination and PX.
UNASSIGNED: Questionnaires were sent to 457 subjects. Responses from 228 (116 in the vaccination group and 112 in the non-vaccinated group) were included in the analysis. Multivariable analysis, which excluded physician recommendation for VZV vaccination as a variable because it was an intermediate factor in the analysis, showed an association between PX and VZV vaccination (odds ratio, 1.38; 95% confidence interval, 1.00-1.92; P = .049).
UNASSIGNED: PX was associated with past VZV vaccination. Physician recommendation for VZV vaccination was an intermediate factor between PX and VZV vaccination.
UNASSIGNED: A case-control study of VZV vaccination was conducted at a community hospital in Ibaraki, Japan. Patients aged 65 years or older who had continuously been patients of the hospital between April 2018 and April 2021 were included in the study. The vaccinated group consisted of 166 VZV-vaccinated patients. The controls consisted of 29 age- and sex-matched patients who did not receive VZV vaccination. A self-administered questionnaire was distributed between August and September 2021. It included the Japanese version of the Primary Care Assessment Tool Short Form (JPCAT-SF) to evaluate PX and included questions about recommendations for VZV vaccination by a physician and the vaccination history of relatives. Multivariable and intermediate factor analyses were used to assess whether there was an association between VZV vaccination and PX.
UNASSIGNED: Questionnaires were sent to 457 subjects. Responses from 228 (116 in the vaccination group and 112 in the non-vaccinated group) were included in the analysis. Multivariable analysis, which excluded physician recommendation for VZV vaccination as a variable because it was an intermediate factor in the analysis, showed an association between PX and VZV vaccination (odds ratio, 1.38; 95% confidence interval, 1.00-1.92; P = .049).
UNASSIGNED: PX was associated with past VZV vaccination. Physician recommendation for VZV vaccination was an intermediate factor between PX and VZV vaccination.
摘要：
■这项研究检查了患者体验(PX，患者在初级保健期间经历的事件，这些事件是以患者为中心的质量的指标）老年人的初级保健和水痘-带状疱疹病毒（VZV）疫苗摄取。
■在茨城县一家社区医院进行了VZV疫苗接种的病例对照研究，日本。在2018年4月至2021年4月期间连续住院的65岁或以上患者被纳入研究。接种组包括166名接种VZV的患者。对照由29名年龄和性别匹配的患者组成，他们没有接受VZV疫苗接种。在2021年8月至9月之间分发了一份自我管理的问卷。它包括用于评估PX的日文版初级保健评估工具简表（JPCAT-SF），并包括有关医生对VZV疫苗接种的建议和亲属疫苗接种史的问题。多变量和中间因素分析用于评估VZV疫苗接种和PX之间是否存在关联。
■向457名受试者发送了问卷。来自228(接种疫苗组中的116和未接种疫苗组中的112)的反应被包括在分析中。多变量分析，其中排除了医生对VZV疫苗接种的建议作为变量，因为它是分析中的中间因素，显示PX和VZV疫苗接种之间存在关联(优势比，1.38；95%置信区间，1.00-1.92；P=.049）。
■PX与过去的VZV疫苗接种有关。医生推荐的VZV疫苗接种是PX和VZV疫苗接种之间的中间因素。
■在茨城县一家社区医院进行了VZV疫苗接种的病例对照研究，日本。在2018年4月至2021年4月期间连续住院的65岁或以上患者被纳入研究。接种组包括166名接种VZV的患者。对照由29名年龄和性别匹配的患者组成，他们没有接受VZV疫苗接种。在2021年8月至9月之间分发了一份自我管理的问卷。它包括用于评估PX的日文版初级保健评估工具简表（JPCAT-SF），并包括有关医生对VZV疫苗接种的建议和亲属疫苗接种史的问题。多变量和中间因素分析用于评估VZV疫苗接种和PX之间是否存在关联。
■向457名受试者发送了问卷。来自228(接种疫苗组中的116和未接种疫苗组中的112)的反应被包括在分析中。多变量分析，其中排除了医生对VZV疫苗接种的建议作为变量，因为它是分析中的中间因素，显示PX和VZV疫苗接种之间存在关联(优势比，1.38；95%置信区间，1.00-1.92；P=.049）。
■PX与过去的VZV疫苗接种有关。医生推荐的VZV疫苗接种是PX和VZV疫苗接种之间的中间因素。
